Jump Financial’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
Jump Financial's EIKN Position: Q3 2026 in Review
Jump Financial reduced its Eikon Therapeutics (EIKN) stake by 42% in Q3 2026, selling an estimated $77.2K and leaving 10,400 shares worth $83.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2213.
Jump Financial first reported a position in EIKN in Q2 2026 and has held it in 2 quarters since. The position peaked at $236K in Q2 2026. 98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.
- Jump Financial held 10,400 shares of Eikon Therapeutics worth $83.6K as of Q3 2026.
- Jump Financial sold 7,669 Eikon Therapeutics shares in Q3 2026, an estimated $77.2K.
- Eikon Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q3 2026, its #2213 holding.
- Jump Financial first reported a position in Eikon Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Jump Financial's Eikon Therapeutics position peaked at $236K in Q2 2026.
- 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.